Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/54047
MetadatoEtiquetaValorIdioma
dc.contributor.author Autor Zumstein, Pascal-
dc.contributor.author Autor Bartetzko, Anissa-
dc.contributor.author Autor Kaethner, Marc-
dc.contributor.author Autor Vetter, Laura-
dc.contributor.author Autor Hemphill, Andrew-
dc.contributor.author Autor Zumkehr, Trix-
dc.contributor.author Autor Laleu, Benoît-
dc.contributor.author Autor Preza Pérez, Matías Facundo-
dc.contributor.author Autor Lundström-Stadelmann, Britta-
dc.contributor.filiacion Filiación Zumstein Pascal-
dc.contributor.filiacion Filiación Bartetzko Anissa-
dc.contributor.filiacion Filiación Kaethner Marc-
dc.contributor.filiacion Filiación Vetter Laura-
dc.contributor.filiacion Filiación Hemphill Andrew-
dc.contributor.filiacion Filiación Zumkehr Trix-
dc.contributor.filiacion Filiación Laleu Benoît-
dc.contributor.filiacion Filiación Preza Pérez Matías Facundo, Universidad de la República (Uruguay). Facultad de Ciencias. Instituto de Biología.-
dc.contributor.filiacion Filiación Lundström-Stadelmann Britta-
dc.date.accessioned Fecha ingreso 2026-03-23T16:09:30Z-
dc.date.available Fecha disponible 2026-03-23T16:09:30Z-
dc.date.issued Año de publicación 2025-
dc.description.abstract Resumen Alveolar echinococcosis (AE) is a life-threatening disease caused by the metacestode stage of the fox tapeworm Echinococcus multilocularis, primarily in the liver. Current drug treatments rely on benzimidazoles, which are not parasiticidal, requiring life-long therapy with significant side effects. Therefore, novel drug treatments are urgently needed. Drug repurposing offers a strategy to identify novel therapies against the neglected disease AE. We report on the in vitro screening of the Pandemic Response Box, an open-access compound library composed of 400 drug-like molecules assembled by Medicines for Malaria Venture (MMV) and the Drugs for Neglected Disease Initiative (DNDi), against E. multilocularis. An overview screen at 10 μM using the metacestode vesicle damage-marker release assay (based on release of phosphoglucose isomerase, PGI) and metacestode vesicle viability assay (based on ATP measurement) identified 37 active compounds. Reassessment in triplicates resulted in five active compounds (alexidine, carbendazim, ESI-09, MMV1581545, oxfendazole) displaying anti-metacestode activity. The parasiticidal activity of these five compounds was evaluated by ATP measurement in germinal layer cells. One compound, ESI-09, acted specifically against E. multilocularis (IC50 on metacestode vesicles 6.06 ± 3.18 μM by PGI release assay and 2.09 ± 0.56 μM by metacestode vesicle viability assay as well as an IC50 of 2.45 ± 0.86 μM on germinal layer cells) with a broad therapeutic window when compared to mammalian cell toxicity. Further experiments applying Seahorse technology and tetramethylrhodamine ethyl ester (TMRE) assay revealed that ESI-09 acts as a mitochondrial uncoupler in parasite cells. However, transmission electron microscopy showed no significant ultrastructural changes in parasite mitochondria, though increased secretion of extracel- lular vesicle-like structures between the tegument and the laminated layer was observed. In summary, screening of the Pandemic Response Box identified ESI-09 as a potential drug candidate for the treatment of AE. Further experiments are needed to evaluate the efficacy of ESI-09 in vivo.es
dc.format.extent Extensión 11 hes
dc.format.mimetype Formato application/pdfes
dc.identifier.citation Citación Zumstein, P, Bartetzko, A, Kaethner, M [y otros autores]. "In vitro screening of the open-access Pandemic Response Box reveals ESI-09 as a compound with activity against Echinococcus multilocularis". International Journal for Parasitology: Drugs and Drug Resistance. [en línea] 2025, 29: 100609. 11 h. DOI: 10.1016/j.ijpddr.2025.100609es
dc.identifier.doi DOI 10.1016/j.ijpddr.2025.100609-
dc.identifier.issn ISSN 2211-3207-
dc.identifier.uri URI https://hdl.handle.net/20.500.12008/54047-
dc.language.iso Idioma enes
dc.publisher Editorial Elsevieres
dc.relation.ispartof EN International Journal for Parasitology: Drugs and Drug Resistance, 2025, 29: 100609.es
dc.rights Derechos Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)es
dc.rights.licence Licencia Atribución/Reconocimiento 4.0 Internacionales
dc.subject Palabras clave Echinococcus mutlilocularises
dc.subject Palabras clave Alveolar echinococcosises
dc.subject Palabras clave Drug repurposinges
dc.subject Palabras clave MMVes
dc.subject Palabras clave DNDies
dc.subject Palabras clave Mitochondrial uncoupleres
dc.title Título In vitro screening of the open-access Pandemic Response Box reveals ESI-09 as a compound with activity against Echinococcus multilocularises
dc.type Tipo de documento Artículoes
FicherosDescripciónTamañoFormato
10.101.j.ijpddr.2025.100609.pdf — 6.95 MB Adobe PDF

Licencia Creative Commons:

Excepto donde se indique lo contrario, la licencia de este ítem se describe como Atribución/Reconocimiento 4.0 Internacional